ArticleInternational journal of molecular medicine2026

Deciphering the CAF‑LCN2 axis: Key to overcoming anti‑PD‑L1 immunotherapy resistance in lung cancer.

Dan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.